Channappanavar, R., Perlman, S., Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 39:5 (2017), 529–539, 10.1007/s00281-017-0629-x.
Lippi, G., Plebani, M., Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med, 2020, 10.1515/cclm-2020-0198 [pii:/j/cclm.ahead-of-print/cclm-2020-0198/cclm-2020-0198.xml.].
Lippi, G., Plebani, M., Henry, B.M., Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta 506 (2020), 145–148, 10.1016/j.cca.2020.03.022.
Tang, N., Li, D., Wang, X., Sun, Z., Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18:4 (2020), 844–847, 10.1111/jth.14768.
Lillicrap, D., Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia. J Thromb Haemost 18:4 (2020), 786–787, 10.1111/jth.14781.
Cui, S., Chen, S., Li, X., Liu, S., Wang, F., Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost., 2020, 10.1111/jth.14830.
Shi, S., Qin, M., Shen, B., Cai, Y., Liu, T., Yang, F., et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol, 2020, 10.1001/jamacardio.2020.0950.
Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int, 2020, 10.1016/j.kint.2020.03.005 pii: S0085-2538(20)30255-6.
Dubar, G., Azria, E., Tesnière, A., Dupont, H., Le Ray, C., Baugnon, T., et al. French Registry on 2009 A/H1N1v during pregnancy. French experience of 2009 A/H1N1v influenza in pregnant women. PLoS One, 5(10), 2010, 10.1371/journal.pone.0013112 pii: e13112.
Louie, J.K., Acosta, M., Jamieson, D.J., Honein, M.A., California Pandemic (H1N1) Working group Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 362:1 (2010), 27–35, 10.1056/NEJMoa0910444.
Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med, 2020, 10.1056/NEJMc2007575.
Taylor, F.B. Jr., Toh, C.H., Hoots, W.K., Levi, M., Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86:5 (2001), 1327–1330.
Chen, R., Zhang, Y., Huang, L., Cheng, B.H., Xia, Z.Y., Meng, Q.T., Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: a case series of 17 patients. Can J Anaesth, 2020, 10.1007/s12630-020-01630-7.
Bauer, M.E., Chiware, R., Pancaro, C., Neuraxial procedures in COVID-19 positive parturients: a review of current reports. Anesth Analg, 2020, 10.1213/ANE.0000000000004831.
Hunt, B., Retter, A., McClintock, C., Practical guidance for the prevention of thrombosis and management of coagulopathy and disseminated intravascular coagulation of patients infected with COVID-19. Thrombosis Haemostasis, 2020, 10.1111/jth.14853 Online ahead of print. PMID: 32302442.
Liu, Y., Chen, H., Tang, K., Guo, Y., Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. J Infect, 2020, 10.1016/j.jinf.2020.02.028 [pii: S0163-4453(20)30109-2].
Zhang, Y., Chen, R., Wang, J., Gong, Y., Zhou, Q., Cheng H-h, et al. Anaesthetic management and clinical outcomes of parturients with COVID-19: a multicentre, retrospective, propensity score matched cohort study. MedRxiv, 2020, 10.1101/2020.03.24.20042176.
Klok, F.A., Kruip, M.J.H.A., van der Meer, N.J.M., Arbous, M.S., Gommers DAMPJ, Kant, K.M., et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res, 2020, 10.1016/j.thromres.2020.04.013 [S0049-3848(20)30120-1].
Tang, N., Bai, H., Chen, X., Gong, J., Li, D., Sun, Z., Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost, 2020, 10.1111/jth.14817.
Susen S, Tacquard CA, Godon A, Mansour A, Guarrigue D, Nguyen P, et al. Traitement anticoagulant pour la prévention du risque thrombotique chez un patient hospitalisé avec COVID-19 et surveillance de l'hémostase. Propositions du GIHP et du GFHT, SFAR 2020. https://sfar.org/traitement-anticoagulant-pour-la-prevention-du-risque-thrombotique-chez-un-patient-hospitalise-avec-covid-19-et-surveillance-de-lhemostase/last accessed April 12 2020.
Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M., et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost., 2020, 10.1111/JTH. 14810.
Sénat, M.V., Sentilhes, L., Battut, A., Benhamou, D., Bydlowski, S., Chantry, A., et al. Postpartum practice: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF). Eur J Obstet Gynecol Reprod Biol 202 (2016 Jul), 1–8, 10.1016/j.ejogrb.2016.04.032.
Wang, J., Hajizadeh, N., Moore, E.E., McIntyre, R.C., Moore, P.K., Veress, L.A., et al. Tissue Plasminogen Activator (tPA) Treatment for COVID-19 associated acute respiratory distress syndrome (ards): a case series. J Thromb Haemost, 2020, 10.1111/jth.14828.